These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 21403904)

  • 21. Immunization of guinea pigs with Salmonella delivered anti-Brucella formulation reduces organs bacterial load and mitigates histopathological consequences of Brucella abortus 544 challenge.
    Lalsiamthara J; Lee JH
    Vet Immunol Immunopathol; 2018 Jan; 195():40-45. PubMed ID: 29249316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advancement of knowledge of Brucella over the past 50 years.
    Olsen SC; Palmer MV
    Vet Pathol; 2014 Nov; 51(6):1076-89. PubMed ID: 24981716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics.
    He Y
    Front Cell Infect Microbiol; 2012; 2():2. PubMed ID: 22919594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brucellosis vaccines based on the open reading frames from genomic island 3 of Brucella abortus.
    Gómez L; Alvarez F; Betancur D; Oñate A
    Vaccine; 2018 May; 36(21):2928-2936. PubMed ID: 29685597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections.
    Zhu L; Feng Y; Zhang G; Jiang H; Zhang Z; Wang N; Ding J; Suo X
    Vaccine; 2016 Jan; 34(3):395-400. PubMed ID: 26626213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The possibility of creating a vaccinal strain of Brucella abortus 19-BA with multiple antibiotic resistance].
    Gorelov VN; Gubina EA; Grekova NA; Skavronskaia AG
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Sep; (9):2-4. PubMed ID: 1759514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brucellosis: a re-emerging zoonosis.
    Seleem MN; Boyle SM; Sriranganathan N
    Vet Microbiol; 2010 Jan; 140(3-4):392-8. PubMed ID: 19604656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-Analysis and Advancement of Brucellosis Vaccinology.
    Carvalho TF; Haddad JP; Paixão TA; Santos RL
    PLoS One; 2016; 11(11):e0166582. PubMed ID: 27846274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune Response to Mucosal
    López-Santiago R; Sánchez-Argáez AB; De Alba-Núñez LG; Baltierra-Uribe SL; Moreno-Lafont MC
    Front Immunol; 2019; 10():1759. PubMed ID: 31481953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
    Al-Mariri A; Abbady AQ
    J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of antibiotics and an immune organism on the causative agent of brucellosis].
    Taran IF; Zamakhaeva EI; Kozlov MP; Pogorelov NA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Mar; 51(3):78-82. PubMed ID: 4830046
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathogenesis and immune response in Brucella infection acquired by the respiratory route.
    Ferrero MC; Alonso Paiva IM; Muñoz González F; Baldi PC
    Microbes Infect; 2020 Oct; 22(9):407-415. PubMed ID: 32535086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of specific cell-mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis human isolate.
    Bagheri Nejad R; Yahyaraeyat R; Es-Haghi A; Nayeri Fasaei B; Zahraei Salehi T
    APMIS; 2019 Dec; 127(12):797-804. PubMed ID: 31514254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nondividing but metabolically active gamma-irradiated Brucella melitensis is protective against virulent B. melitensis challenge in mice.
    Magnani DM; Harms JS; Durward MA; Splitter GA
    Infect Immun; 2009 Nov; 77(11):5181-9. PubMed ID: 19703982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.
    Golshani M; Rafati S; Dashti A; Gholami E; Siadat SD; Oloomi M; Jafari A; Bouzari S
    Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brucella abortus ΔrpoE1 confers protective immunity against wild type challenge in a mouse model of brucellosis.
    Willett JW; Herrou J; Czyz DM; Cheng JX; Crosson S
    Vaccine; 2016 Sep; 34(42):5073-5081. PubMed ID: 27591954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine Candidate Brucella melitensis 16M
    Hensel ME; Garcia-Gonzalez DG; Chaki SP; Hartwig A; Gordy PW; Bowen R; Ficht TA; Arenas-Gamboa AM
    mSphere; 2020 May; 5(3):. PubMed ID: 32404509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.
    Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A
    Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brucella discriminates between mouse dendritic cell subsets upon in vitro infection.
    Papadopoulos A; Gagnaire A; Degos C; de Chastellier C; Gorvel JP
    Virulence; 2016; 7(1):33-44. PubMed ID: 26606688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of plasma sphingosine 1-phosphate, hepcidin and cardiovascular damage biomarkers (cardiac troponin I and homocysteine) in rats infected with brucellosis and vaccinated (Rev-1, RB-51).
    Azimzadeh K; Nasrollahi Nargesabad R; Vousooghi N
    Microb Pathog; 2017 Aug; 109():67-70. PubMed ID: 28533142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.